DNA Methylation in Gynecological Cancers
Author Information
Author(s): Yang Hui-Juan, Liu Vincent WS, Wang Yue, Tsang Percy CK, Ngan Hextan YS
Primary Institution: Fudan University Cancer Hospital, Shanghai, China
Hypothesis
Differential DNA methylation profiles exist in gynecological cancers and correlate with clinico-pathological data.
Conclusion
Differential methylation profiles occur in the three types of gynecologic cancer, suggesting that detection of methylation for critical loci could be useful as epigenetic markers in tumor classification.
Supporting Evidence
- Hypermethylation of APC and p16 was detected across the three cancers.
- Specific methylation patterns were found in cervical cancer (CDH1, DAPK, MGMT, MINT2), endometrial cancer (CASP8, CDH13, hMLH1, p73), and ovarian cancer (BRCA1, p14, p15, RIZ1, TMS1).
- Methylation for at least one gene was detectable in 72.4% of cervical cancers, 66.7% of endometrial cancers, and 51.0% of ovarian cancers.
Takeaway
This study looked at how certain genes are changed in cancer and found that different types of gynecological cancers have different patterns of these changes.
Methodology
The study used pooled DNA approach and methylation-specific PCR to analyze the methylation status of 34 gene loci in tumor and normal tissues from patients with cervical, endometrial, and ovarian cancers.
Limitations
The study suggests that more cases are needed for confirmation of findings, particularly in endometrial and ovarian cancers.
Participant Demographics
Patients included 127 with cervical cancer, 60 with endometrial cancer, and 50 with ovarian cancer, with ages ranging from 22 to 101 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% confidence interval: 102.8–125.8 months
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website